ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 7.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $38,000 | +171.4% | 63,100 | +2963.1% | 0.00% | +300.0% |
| Q1 2018 | $14,000 | -91.2% | 2,060 | -96.3% | 0.00% | -85.7% |
| Q4 2017 | $159,000 | -45.2% | 55,701 | -26.4% | 0.01% | -36.4% |
| Q3 2017 | $290,000 | -59.6% | 75,725 | -45.6% | 0.01% | -57.7% |
| Q2 2017 | $717,000 | +362.6% | 139,170 | +530.3% | 0.03% | +333.3% |
| Q1 2017 | $155,000 | -45.2% | 22,081 | -23.8% | 0.01% | -45.5% |
| Q4 2016 | $283,000 | +34.1% | 28,983 | -45.3% | 0.01% | +22.2% |
| Q3 2016 | $211,000 | -16.9% | 52,972 | +36.2% | 0.01% | -30.8% |
| Q2 2016 | $254,000 | -22.8% | 38,891 | -55.5% | 0.01% | -38.1% |
| Q1 2016 | $329,000 | +10.8% | 87,448 | +80.9% | 0.02% | +31.2% |
| Q4 2015 | $297,000 | – | 48,333 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |